SCHEMBL3466836

SCHEMBL3466836

COC(=O)C(Cc1ccccc1)NC(=O)c1nn(CCc2ccccc2)cc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
RAB9A P51151 1/20 0.47
ATM Q13315 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
GLA P06280 1/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
THRB P10828 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TACR3 P29371 1/20 0.45
LNPEP Q9UIQ6 3/20 0.45
ERAP1 Q9NZ08 2/20 0.45
ERAP2 Q6P179 1/20 0.45
CNR1 P21554 2/20 0.45
CNR2 P34972 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467369 0.81 CAPN1 (0.46) ADORA3ADORA2AADORA2BADORA1
SCHEMBL3466837 0.77 ALDH1A1 (0.42) ADORA3ADORA2AADORA2BADORA1ALDH1A1
SCHEMBL30272415 0.74 ATM (0.58) GAARAB9AATMALDH1A1LMNA
SCHEMBL4935854 0.73 SMN1; SMN2 (0.46) ADORA3ADORA2AADORA2BADORA1ALDH1A1
SCHEMBL3468846 0.73 FTO (0.46) ADORA3ADORA2AADORA1ALDH1A1
SCHEMBL31206887 0.71 GAA (0.76) GAARAB9AATMALDH1A1LMNA
SCHEMBL2461492 0.71 GAA (0.76) GAARAB9AATMALDH1A1LMNA
SCHEMBL1793176 0.71 GAA (0.76) GAARAB9AATMALDH1A1LMNA
SCHEMBL9088699 0.71 RAB9A (0.71) GAARAB9AATMALDH1A1LMNA
SCHEMBL9088697 0.71 RAB9A (0.71) GAARAB9AATMALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010074480-A2 NOVEL PYRAZOLODIAZEPINE COMPOUNDS AS A TRANSGLUTAMINASE INHIBITOR, THE PREPARATION METHOD THEREOF AND A COMPOSITION CONTAINING THE SAME NATIONAL CANCER CENTER (KR) 2010-07-01 WO disclosed